We’ve seen at least three articles explaining why the Fed failed to increase interest rates last Thursday. One says Goldman Sachs is calling …
In a research report published yesterday, Piper Jaffray analyst Gene Munster reiterated an Overweight rating on shares of Amazon.com, Inc.
William Blair’s healthcare analyst John Sonnier weighed in with a favorable report on Gilead Sciences, Inc. (NASDAQ:GILD), after the company announced positive clinical data featuring the company’s next-generation, …
In a research report released Monday, Canaccord analyst John Newman reiterated a Buy rating on shares of Palatin Technologies, Inc. (NYSEMKT:PTN) with a $6 price …
In a research report released today, Cantor analyst Youssef Squali provided a commentary on Netflix, Inc. (NASDAQ:NFLX), as the online streaming giant won four Emmys …
In a research report published today, BTIG analyst Tim Chiang reiterated a Buy rating on shares of Synthetic Biologics Inc (NYSEMKT:SYN) with a price …
Canaccord Genuity analyst Michael Walkley released a report yesterday highlighting his bullish views on Apple Inc. (NASDAQ:AAPL), noting that the company’s smartphone market …
Gilead Sciences, Inc. (NASDAQ:GILD) announced topline results from four international Phase 3 clinical studies (ASTRAL-1, ASTRAL-2, ASTRAL-3 and ASTRAL-4) evaluating a once-daily, fixed-dose …
Apple Inc. (NASDAQ:AAPL) announced iPhone® 6s and iPhone 6s Plus, the most advanced iPhones ever, will be available at 8:00 a.
Last week’s no-hike Fed decision raises questions about the outlook for the US economy, but another delay in tightening monetary policy revived demand …
